Cargando…

Correction: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy

Detalles Bibliográficos
Autores principales:	Elias, D., Vever, H., Lænkholm, A.-V., Gjerstorff, M. F., Yde, C. W., Lykkesfeldt, A. E., Ditzel, H. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7056636/ https://www.ncbi.nlm.nih.gov/pubmed/31712727 http://dx.doi.org/10.1038/s41388-019-1096-8

Ejemplares similares

MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit
por: Løkkegaard, Sanne, et al.
Publicado: (2021)

Aurora kinase B is important for antiestrogen resistant cell growth and a potential biomarker for tamoxifen resistant breast cancer
por: Larsen, Sarah L, et al.
Publicado: (2015)

Sustained compensatory p38 MAPK signaling following treatment with MAPK inhibitors induces the immunosuppressive protein CD73 in cancer: combined targeting could improve outcomes
por: Terp, Mikkel G., et al.
Publicado: (2021)

Quantitative proteomics reveals novel proteins and central pathways associated with endocrine resistance in breast cancer
por: Løkkegaard, S, et al.
Publicado: (2011)

Src Drives Growth of Antiestrogen Resistant Breast Cancer Cell Lines and Is a Marker for Reduced Benefit of Tamoxifen Treatment
por: Larsen, Sarah L., et al.
Publicado: (2015)

Global MicroRNA Expression Profiling of High-Risk ER+ Breast Cancers from Patients Receiving Adjuvant Tamoxifen Mono-Therapy: A DBCG Study
por: Lyng, Maria B., et al.
Publicado: (2012)

Gene Expression Signatures That Predict Outcome of Tamoxifen-Treated Estrogen Receptor-Positive, High-Risk, Primary Breast Cancer Patients: A DBCG Study
por: Lyng, Maria B., et al.
Publicado: (2013)

Integrative analysis of miRNA and gene expression reveals regulatory networks in tamoxifen-resistant breast cancer
por: Joshi, Tejal, et al.
Publicado: (2016)

Fyn regeneration
por: Short, Ben
Publicado: (2012)

Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas
por: Palomero, Teresa, et al.
Publicado: (2014)

Development and characterization of a tamoxifen-resistant breast carcinoma xenograft
por: Naundorf, H, et al.
Publicado: (2000)

Integrative analyses of gene expression and DNA methylation profiles in breast cancer cell line models of tamoxifen-resistance indicate a potential role of cells with stem-like properties
por: Lin, Xue, et al.
Publicado: (2013)

Oncogenic cancer/testis antigens: prime candidates for immunotherapy
por: Gjerstorff, Morten F., et al.
Publicado: (2015)

Endocrine and clinical consequences of combination tamoxifen-aminoglutethimide in postmenopausal breast cancer.
por: Dowsett, M., et al.
Publicado: (1984)

ZBED1 Regulates Genes Important for Multiple Biological Processes of the Placenta
por: Johansen, Simone, et al.
Publicado: (2022)

Fyn Kinase Is Required for Optimal Humoral Responses
por: Chaimowitz, Natalia S., et al.
Publicado: (2013)

Evaluation of SPP1/osteopontin expression as predictor of recurrence in tamoxifen treated breast cancer
por: Göthlin Eremo, Anna, et al.
Publicado: (2020)

Expression Analysis of Fyn and Bat3 Signal Transduction Molecules in Patients with Chronic Lymphocytic Leukemia
por: Hosseini-Valiki, Fereshteh, et al.
Publicado: (2020)

Fyn Mediates Leptin Actions in the Thymus of Rodents
por: Girasol, Alessandra, et al.
Publicado: (2009)

Targeting two distinct epitopes on human CD73 with a bispecific antibody improves anticancer activity
por: Gammelgaard, Odd L, et al.
Publicado: (2022)

Inhibition of redox/Fyn/c-Cbl pathway function by Cdc42 controls tumour initiation capacity and tamoxifen sensitivity in basal-like breast cancer cells
por: Chen, Hsing-Yu, et al.
Publicado: (2013)

Effects of the antioestrogen tamoxifen on the cell cycle kinetics of the human breast cancer cell line, MCF-7.
por: Lykkesfeldt, A. E., et al.
Publicado: (1984)

miRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets
por: Klinge, Carolyn M.
Publicado: (2015)

Restriction of GAGE protein expression to subpopulations of cancer cells is independent of genotype and may limit the use of GAGE proteins as targets for cancer immunotherapy
por: Gjerstorff, M F, et al.
Publicado: (2006)

Fyn kinase inhibition as a novel therapy for Alzheimer’s disease
por: Nygaard, Haakon B, et al.
Publicado: (2014)

Tyrosine Phosphorylation of Tau by the Src Family Kinases Lck and Fyn
por: Scales, Timothy ME, et al.
Publicado: (2011)

Exome sequencing identifies somatic point mutations associated with acquired endocrine resistance in breast cancer cell lines
por: Ehlers, Natasja S, et al.
Publicado: (2012)

Identification of alternatively spliced Dab1 and Fyn isoforms in pig
por: Long, Huan, et al.
Publicado: (2011)

Positive effect of tamoxifen as part of adjuvant chemo-endocrine therapy for breast cancer. Hokkaido Adjuvant Chemo-Endocrine Therapy for Breast Cancer Study Group.
por: Uchino, J., et al.
Publicado: (1994)

The impact of endoxifen-guided tamoxifen dose reductions on endocrine side-effects in patients with primary breast cancer
por: Buijs, S.M., et al.
Publicado: (2023)

Analysis of GAGE, NY-ESO-1 and SP17 cancer/testis antigen expression in early stage non-small cell lung carcinoma
por: Gjerstorff, Morten F, et al.
Publicado: (2013)

Lack of ADAM2, CALR3 and SAGE1 Cancer/Testis Antigen Expression in Lung and Breast Cancer
por: Maheswaran, Emeaga, et al.
Publicado: (2015)

Human DREF/ZBED1 is a nuclear protein widely expressed in multiple cell types derived from all three primary germ layers
por: Hansen, Simone Valentin, et al.
Publicado: (2018)

Fyn‐binding protein ADAP supports actin organization in podocytes
por: Wu, Zhenzhen, et al.
Publicado: (2017)

The interaction of the ER with ERBB2 and PI3K results in elevated levels of AKT and p90(RSK )in tamoxifen-resistant MCF-7 cells
por: Pancholi, S, et al.
Publicado: (2005)

Basal cell adenocarcinoma of the supraglottic larynx: treatment of recurrent disease with tamoxifen
por: Bailey, Christopher H., et al.
Publicado: (2011)

Itk and Fyn Make Independent Contributions to T Cell Activation
por: Liao, X. Charlene, et al.
Publicado: (1997)

Signaling for NKT cell development: the SAP–FynT connection
por: Borowski, Christine, et al.
Publicado: (2005)

Fyn-Dependent Gene Networks in Acute Ethanol Sensitivity
por: Farris, Sean P., et al.
Publicado: (2013)

Regulatory Effects of Fyn on Trophoblast Cell Behaviors and Function
por: Liu, Qian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0iejdj7284445qsetsmsdsebi7